Recent Updates
Recently added Catalysts

Trigeminal Nerve Stimulation

Phase 2

Epilepsy | Unknown | Neurology |Boston Scientific Corporation|Last Updated: Jun 3, 2013

Success Probability
Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
Premium
Market & Valuation
rNPV $3.2B
Market Size $9.4B
Revenue Basis $1.6B
Competitors 6
Premium
Trial Design
RandomizedDouble-BlindCONTROLLEDDMC
Total Trials1
Total Enrollment50
FDA Designations
No designations recorded
Clinical Trials (1)
NCT IDTitlePhaseStatusEnrollmentVelocityDesignStartCompletionLast UpdatedSitesCountries
NCT01159431External Trigeminal Nerve Stimulation for EpilepsyPHASE2 COMPLETED 50Jan 1, 2008Jun 1, 2011Jun 3, 20132 United States
Unlock Drug Trial Details
Study Endpoints
Primary Endpoints
50% Responder Rate
Treatment period, 18 weeks (end of double blind period) compared with first 6 weeks

Change in responder rate, at end of study (18 weeks) Absolute percent of subjects with 50% reduction in seizures, 18 weeks compared with 6 weeks Note, the number is not a mean or median, but a fixed percentage.

Time to the 4th Seizure
treatment period (18-weeks)

Number of Days to the 4th seizure

Change in Seizure Frequency
18 weeks

Percent change in seizure frequency from baseline

Secondary Endpoints
Response Ratio: Mean Percent Change in Seizures
18 weeks
Mood
18-weeks
Unlock Study Endpoints
Study Design & Arms
AllocationRANDOMIZED
MaskingQUADRUPLE
ModelPARALLEL
PurposeTREATMENT
Treatment Arms
ArmTypeDescription
ActiveEXPERIMENTAL -
ControlOTHER -
Interventions
NameTypeDescription
Trigeminal Nerve StimulationDEVICEExternal stimulation of the supraorbital branch of the Trigeminal Nerve using a digital TENs unit
Unlock Study Design Details
Eligibility Criteria
Age Range18 Years — 70 Years
SexALL
Healthy VolunteersNo
Study Sites2

Inclusion Criteria: * Ages 18 - 70; * No serious or progressive medical illness; * A history of intractable partial seizures; * At least two complex partial or tonic clonic generalized seizures per month in the last two consecutive months; * MRI or EEG consistent with localization-related or partia...

Countries:United States
Unlock Eligibility Criteria